This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Facing challenges in saving for a house? Explore effective strategies to overcome obstacles and boost your savings.
9,628 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
A little-known ETF with amplified crude exposure has jumped 289% year-to-date as oil holds near $80, highlighting the...
The trade desk stock swung sharply today as a major client questioned DSP usage. This piece breaks down what happened...
Two early leaders in the electric air taxi race collide with a policy signal that could tilt the field. This analysis...
A major fund just increased its stake in Molina Healthcare, while the stock trades lower. This guide breaks down what...
In a market rotating away from fast-growing tech, three dividend aristocrat stocks that have raised payouts for decad...
For the next 10 years, dividend stocks hold next potential with steady income and growth. Discover four dependable na...
Fed’s Bowman signals a hawkish tilt, saying she’s penciled in three rate cuts by year-end 2026 to bolster the labor m...
Oil prices near $100 a barrel collide with Brazil's sugar-and-ethanol balance, threatening tighter sugar supplies jus...
As U.S. recession odds rise, XRP could see amplified volatility driven by flow dynamics and policy timing. Here is ho...
Robotaxi chatter tends to focus on all-or-nothing automation. This article explains why Uber's hybrid network could b...
Wall Street predicts these three AI stocks could double within four years as demand for AI infrastructure and memory ...